Global mRNA Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global mRNA Therapy market size was valued at US$ 35730 million in 2023. With growing demand in downstream market, the mRNA Therapy is forecast to a readjusted size of US$ 87730 million by 2030 with a CAGR of 13.7% during review period.
The research report highlights the growth potential of the global mRNA Therapy market. mRNA Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Therapy market.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on mRNA Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Therapy market. It may include historical data, market segmentation by Type (e.g., Vaccine, Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Therapy industry. This include advancements in mRNA Therapy technology, mRNA Therapy new entrants, mRNA Therapy new investment, and other innovations that are shaping the future of mRNA Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Therapy market.
Market Segmentation:
mRNA Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global mRNA Therapy market size was valued at US$ 35730 million in 2023. With growing demand in downstream market, the mRNA Therapy is forecast to a readjusted size of US$ 87730 million by 2030 with a CAGR of 13.7% during review period.
The research report highlights the growth potential of the global mRNA Therapy market. mRNA Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Therapy market.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on mRNA Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Therapy market. It may include historical data, market segmentation by Type (e.g., Vaccine, Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Therapy industry. This include advancements in mRNA Therapy technology, mRNA Therapy new entrants, mRNA Therapy new investment, and other innovations that are shaping the future of mRNA Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Therapy market.
Market Segmentation:
mRNA Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Vaccine
- Drugs
- mRNA Targeted Delivery in vivo
- Genetically Modified T cells
- Transforming Nanoparticles to Develop Immunotherapy for Cancer
- Small Molecule Drugs Discovery
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Moderna
- BioNTech
- Pfizer
- Arcturus Therapeutics Holdings Inc.
- Astrazeneca
- CureVac
- Translate Bio
- Regeneron Pharmaceuticals
- Arcturus Therapeutics
- Takeda Pharmaceutical Company
- Novartis
- Sanofi
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Therapy Market Size 2019-2030
2.1.2 mRNA Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Therapy Segment by Type
2.2.1 Vaccine
2.2.2 Drugs
2.3 mRNA Therapy Market Size by Type
2.3.1 mRNA Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Therapy Market Size Market Share by Type (2019-2024)
2.4 mRNA Therapy Segment by Application
2.4.1 mRNA Targeted Delivery in vivo
2.4.2 Genetically Modified T cells
2.4.3 Transforming Nanoparticles to Develop Immunotherapy for Cancer
2.4.4 Small Molecule Drugs Discovery
2.5 mRNA Therapy Market Size by Application
2.5.1 mRNA Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Therapy Market Size Market Share by Application (2019-2024)
3 MRNA THERAPY MARKET SIZE BY PLAYER
3.1 mRNA Therapy Market Size Market Share by Players
3.1.1 Global mRNA Therapy Revenue by Players (2019-2024)
3.1.2 Global mRNA Therapy Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA THERAPY BY REGIONS
4.1 mRNA Therapy Market Size by Regions (2019-2024)
4.2 Americas mRNA Therapy Market Size Growth (2019-2024)
4.3 APAC mRNA Therapy Market Size Growth (2019-2024)
4.4 Europe mRNA Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas mRNA Therapy Market Size by Country (2019-2024)
5.2 Americas mRNA Therapy Market Size by Type (2019-2024)
5.3 Americas mRNA Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Therapy Market Size by Region (2019-2024)
6.2 APAC mRNA Therapy Market Size by Type (2019-2024)
6.3 APAC mRNA Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Therapy by Country (2019-2024)
7.2 Europe mRNA Therapy Market Size by Type (2019-2024)
7.3 Europe mRNA Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Therapy by Region (2019-2024)
8.2 Middle East & Africa mRNA Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA THERAPY MARKET FORECAST
10.1 Global mRNA Therapy Forecast by Regions (2025-2030)
10.1.1 Global mRNA Therapy Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Therapy Forecast
10.1.3 APAC mRNA Therapy Forecast
10.1.4 Europe mRNA Therapy Forecast
10.1.5 Middle East & Africa mRNA Therapy Forecast
10.2 Americas mRNA Therapy Forecast by Country (2025-2030)
10.2.1 United States mRNA Therapy Market Forecast
10.2.2 Canada mRNA Therapy Market Forecast
10.2.3 Mexico mRNA Therapy Market Forecast
10.2.4 Brazil mRNA Therapy Market Forecast
10.3 APAC mRNA Therapy Forecast by Region (2025-2030)
10.3.1 China mRNA Therapy Market Forecast
10.3.2 Japan mRNA Therapy Market Forecast
10.3.3 Korea mRNA Therapy Market Forecast
10.3.4 Southeast Asia mRNA Therapy Market Forecast
10.3.5 India mRNA Therapy Market Forecast
10.3.6 Australia mRNA Therapy Market Forecast
10.4 Europe mRNA Therapy Forecast by Country (2025-2030)
10.4.1 Germany mRNA Therapy Market Forecast
10.4.2 France mRNA Therapy Market Forecast
10.4.3 UK mRNA Therapy Market Forecast
10.4.4 Italy mRNA Therapy Market Forecast
10.4.5 Russia mRNA Therapy Market Forecast
10.5 Middle East & Africa mRNA Therapy Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Therapy Market Forecast
10.5.2 South Africa mRNA Therapy Market Forecast
10.5.3 Israel mRNA Therapy Market Forecast
10.5.4 Turkey mRNA Therapy Market Forecast
10.5.5 GCC Countries mRNA Therapy Market Forecast
10.6 Global mRNA Therapy Forecast by Type (2025-2030)
10.7 Global mRNA Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna mRNA Therapy Product Offered
11.1.3 Moderna mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Moderna Main Business Overview
11.1.5 Moderna Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech mRNA Therapy Product Offered
11.2.3 BioNTech mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer mRNA Therapy Product Offered
11.3.3 Pfizer mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Arcturus Therapeutics Holdings Inc.
11.4.1 Arcturus Therapeutics Holdings Inc. Company Information
11.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offered
11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arcturus Therapeutics Holdings Inc. Main Business Overview
11.4.5 Arcturus Therapeutics Holdings Inc. Latest Developments
11.5 Astrazeneca
11.5.1 Astrazeneca Company Information
11.5.2 Astrazeneca mRNA Therapy Product Offered
11.5.3 Astrazeneca mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Astrazeneca Main Business Overview
11.5.5 Astrazeneca Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac mRNA Therapy Product Offered
11.6.3 CureVac mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Translate Bio
11.7.1 Translate Bio Company Information
11.7.2 Translate Bio mRNA Therapy Product Offered
11.7.3 Translate Bio mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Translate Bio Main Business Overview
11.7.5 Translate Bio Latest Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Information
11.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Offered
11.8.3 Regeneron Pharmaceuticals mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Regeneron Pharmaceuticals Main Business Overview
11.8.5 Regeneron Pharmaceuticals Latest Developments
11.9 Arcturus Therapeutics
11.9.1 Arcturus Therapeutics Company Information
11.9.2 Arcturus Therapeutics mRNA Therapy Product Offered
11.9.3 Arcturus Therapeutics mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Arcturus Therapeutics Main Business Overview
11.9.5 Arcturus Therapeutics Latest Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Information
11.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Offered
11.10.3 Takeda Pharmaceutical Company mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceutical Company Main Business Overview
11.10.5 Takeda Pharmaceutical Company Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis mRNA Therapy Product Offered
11.11.3 Novartis mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi mRNA Therapy Product Offered
11.12.3 Sanofi mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sanofi Main Business Overview
11.12.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Therapy Market Size 2019-2030
2.1.2 mRNA Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Therapy Segment by Type
2.2.1 Vaccine
2.2.2 Drugs
2.3 mRNA Therapy Market Size by Type
2.3.1 mRNA Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Therapy Market Size Market Share by Type (2019-2024)
2.4 mRNA Therapy Segment by Application
2.4.1 mRNA Targeted Delivery in vivo
2.4.2 Genetically Modified T cells
2.4.3 Transforming Nanoparticles to Develop Immunotherapy for Cancer
2.4.4 Small Molecule Drugs Discovery
2.5 mRNA Therapy Market Size by Application
2.5.1 mRNA Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Therapy Market Size Market Share by Application (2019-2024)
3 MRNA THERAPY MARKET SIZE BY PLAYER
3.1 mRNA Therapy Market Size Market Share by Players
3.1.1 Global mRNA Therapy Revenue by Players (2019-2024)
3.1.2 Global mRNA Therapy Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MRNA THERAPY BY REGIONS
4.1 mRNA Therapy Market Size by Regions (2019-2024)
4.2 Americas mRNA Therapy Market Size Growth (2019-2024)
4.3 APAC mRNA Therapy Market Size Growth (2019-2024)
4.4 Europe mRNA Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas mRNA Therapy Market Size by Country (2019-2024)
5.2 Americas mRNA Therapy Market Size by Type (2019-2024)
5.3 Americas mRNA Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Therapy Market Size by Region (2019-2024)
6.2 APAC mRNA Therapy Market Size by Type (2019-2024)
6.3 APAC mRNA Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe mRNA Therapy by Country (2019-2024)
7.2 Europe mRNA Therapy Market Size by Type (2019-2024)
7.3 Europe mRNA Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Therapy by Region (2019-2024)
8.2 Middle East & Africa mRNA Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MRNA THERAPY MARKET FORECAST
10.1 Global mRNA Therapy Forecast by Regions (2025-2030)
10.1.1 Global mRNA Therapy Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Therapy Forecast
10.1.3 APAC mRNA Therapy Forecast
10.1.4 Europe mRNA Therapy Forecast
10.1.5 Middle East & Africa mRNA Therapy Forecast
10.2 Americas mRNA Therapy Forecast by Country (2025-2030)
10.2.1 United States mRNA Therapy Market Forecast
10.2.2 Canada mRNA Therapy Market Forecast
10.2.3 Mexico mRNA Therapy Market Forecast
10.2.4 Brazil mRNA Therapy Market Forecast
10.3 APAC mRNA Therapy Forecast by Region (2025-2030)
10.3.1 China mRNA Therapy Market Forecast
10.3.2 Japan mRNA Therapy Market Forecast
10.3.3 Korea mRNA Therapy Market Forecast
10.3.4 Southeast Asia mRNA Therapy Market Forecast
10.3.5 India mRNA Therapy Market Forecast
10.3.6 Australia mRNA Therapy Market Forecast
10.4 Europe mRNA Therapy Forecast by Country (2025-2030)
10.4.1 Germany mRNA Therapy Market Forecast
10.4.2 France mRNA Therapy Market Forecast
10.4.3 UK mRNA Therapy Market Forecast
10.4.4 Italy mRNA Therapy Market Forecast
10.4.5 Russia mRNA Therapy Market Forecast
10.5 Middle East & Africa mRNA Therapy Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Therapy Market Forecast
10.5.2 South Africa mRNA Therapy Market Forecast
10.5.3 Israel mRNA Therapy Market Forecast
10.5.4 Turkey mRNA Therapy Market Forecast
10.5.5 GCC Countries mRNA Therapy Market Forecast
10.6 Global mRNA Therapy Forecast by Type (2025-2030)
10.7 Global mRNA Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna mRNA Therapy Product Offered
11.1.3 Moderna mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Moderna Main Business Overview
11.1.5 Moderna Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech mRNA Therapy Product Offered
11.2.3 BioNTech mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer mRNA Therapy Product Offered
11.3.3 Pfizer mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Arcturus Therapeutics Holdings Inc.
11.4.1 Arcturus Therapeutics Holdings Inc. Company Information
11.4.2 Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offered
11.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Arcturus Therapeutics Holdings Inc. Main Business Overview
11.4.5 Arcturus Therapeutics Holdings Inc. Latest Developments
11.5 Astrazeneca
11.5.1 Astrazeneca Company Information
11.5.2 Astrazeneca mRNA Therapy Product Offered
11.5.3 Astrazeneca mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Astrazeneca Main Business Overview
11.5.5 Astrazeneca Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac mRNA Therapy Product Offered
11.6.3 CureVac mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Translate Bio
11.7.1 Translate Bio Company Information
11.7.2 Translate Bio mRNA Therapy Product Offered
11.7.3 Translate Bio mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Translate Bio Main Business Overview
11.7.5 Translate Bio Latest Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Information
11.8.2 Regeneron Pharmaceuticals mRNA Therapy Product Offered
11.8.3 Regeneron Pharmaceuticals mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Regeneron Pharmaceuticals Main Business Overview
11.8.5 Regeneron Pharmaceuticals Latest Developments
11.9 Arcturus Therapeutics
11.9.1 Arcturus Therapeutics Company Information
11.9.2 Arcturus Therapeutics mRNA Therapy Product Offered
11.9.3 Arcturus Therapeutics mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Arcturus Therapeutics Main Business Overview
11.9.5 Arcturus Therapeutics Latest Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Information
11.10.2 Takeda Pharmaceutical Company mRNA Therapy Product Offered
11.10.3 Takeda Pharmaceutical Company mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Pharmaceutical Company Main Business Overview
11.10.5 Takeda Pharmaceutical Company Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis mRNA Therapy Product Offered
11.11.3 Novartis mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi mRNA Therapy Product Offered
11.12.3 Sanofi mRNA Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sanofi Main Business Overview
11.12.5 Sanofi Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Vaccine
Table 3. Major Players of Drugs
Table 4. mRNA Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 7. mRNA Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 10. Global mRNA Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global mRNA Therapy Revenue Market Share by Player (2019-2024)
Table 12. mRNA Therapy Key Players Head office and Products Offered
Table 13. mRNA Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global mRNA Therapy Market Size Market Share by Regions (2019-2024)
Table 18. Global mRNA Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global mRNA Therapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas mRNA Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas mRNA Therapy Market Size Market Share by Country (2019-2024)
Table 22. Americas mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 24. Americas mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 26. APAC mRNA Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC mRNA Therapy Market Size Market Share by Region (2019-2024)
Table 28. APAC mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 30. APAC mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 32. Europe mRNA Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe mRNA Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 36. Europe mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa mRNA Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa mRNA Therapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of mRNA Therapy
Table 45. Key Market Challenges & Risks of mRNA Therapy
Table 46. Key Industry Trends of mRNA Therapy
Table 47. Global mRNA Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global mRNA Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global mRNA Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global mRNA Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Moderna Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 52. Moderna mRNA Therapy Product Offered
Table 53. Moderna mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Moderna Main Business
Table 55. Moderna Latest Developments
Table 56. BioNTech Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 57. BioNTech mRNA Therapy Product Offered
Table 58. BioNTech Main Business
Table 59. BioNTech mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. BioNTech Latest Developments
Table 61. Pfizer Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 62. Pfizer mRNA Therapy Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. Arcturus Therapeutics Holdings Inc. Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 67. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offered
Table 68. Arcturus Therapeutics Holdings Inc. Main Business
Table 69. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arcturus Therapeutics Holdings Inc. Latest Developments
Table 71. Astrazeneca Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 72. Astrazeneca mRNA Therapy Product Offered
Table 73. Astrazeneca Main Business
Table 74. Astrazeneca mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Astrazeneca Latest Developments
Table 76. CureVac Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 77. CureVac mRNA Therapy Product Offered
Table 78. CureVac Main Business
Table 79. CureVac mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. CureVac Latest Developments
Table 81. Translate Bio Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 82. Translate Bio mRNA Therapy Product Offered
Table 83. Translate Bio Main Business
Table 84. Translate Bio mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Translate Bio Latest Developments
Table 86. Regeneron Pharmaceuticals Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 87. Regeneron Pharmaceuticals mRNA Therapy Product Offered
Table 88. Regeneron Pharmaceuticals Main Business
Table 89. Regeneron Pharmaceuticals mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Regeneron Pharmaceuticals Latest Developments
Table 91. Arcturus Therapeutics Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 92. Arcturus Therapeutics mRNA Therapy Product Offered
Table 93. Arcturus Therapeutics Main Business
Table 94. Arcturus Therapeutics mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Arcturus Therapeutics Latest Developments
Table 96. Takeda Pharmaceutical Company Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 97. Takeda Pharmaceutical Company mRNA Therapy Product Offered
Table 98. Takeda Pharmaceutical Company Main Business
Table 99. Takeda Pharmaceutical Company mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Takeda Pharmaceutical Company Latest Developments
Table 101. Novartis Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 102. Novartis mRNA Therapy Product Offered
Table 103. Novartis mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Sanofi Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 107. Sanofi mRNA Therapy Product Offered
Table 108. Sanofi Main Business
Table 109. Sanofi mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Sanofi Latest Developments
Table 1. mRNA Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Vaccine
Table 3. Major Players of Drugs
Table 4. mRNA Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 7. mRNA Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 10. Global mRNA Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global mRNA Therapy Revenue Market Share by Player (2019-2024)
Table 12. mRNA Therapy Key Players Head office and Products Offered
Table 13. mRNA Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global mRNA Therapy Market Size Market Share by Regions (2019-2024)
Table 18. Global mRNA Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global mRNA Therapy Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas mRNA Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas mRNA Therapy Market Size Market Share by Country (2019-2024)
Table 22. Americas mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 24. Americas mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 26. APAC mRNA Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC mRNA Therapy Market Size Market Share by Region (2019-2024)
Table 28. APAC mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 30. APAC mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 32. Europe mRNA Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe mRNA Therapy Market Size Market Share by Country (2019-2024)
Table 34. Europe mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 36. Europe mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa mRNA Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa mRNA Therapy Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa mRNA Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa mRNA Therapy Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa mRNA Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa mRNA Therapy Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of mRNA Therapy
Table 45. Key Market Challenges & Risks of mRNA Therapy
Table 46. Key Industry Trends of mRNA Therapy
Table 47. Global mRNA Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global mRNA Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global mRNA Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global mRNA Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Moderna Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 52. Moderna mRNA Therapy Product Offered
Table 53. Moderna mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Moderna Main Business
Table 55. Moderna Latest Developments
Table 56. BioNTech Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 57. BioNTech mRNA Therapy Product Offered
Table 58. BioNTech Main Business
Table 59. BioNTech mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. BioNTech Latest Developments
Table 61. Pfizer Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 62. Pfizer mRNA Therapy Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. Arcturus Therapeutics Holdings Inc. Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 67. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offered
Table 68. Arcturus Therapeutics Holdings Inc. Main Business
Table 69. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Arcturus Therapeutics Holdings Inc. Latest Developments
Table 71. Astrazeneca Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 72. Astrazeneca mRNA Therapy Product Offered
Table 73. Astrazeneca Main Business
Table 74. Astrazeneca mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Astrazeneca Latest Developments
Table 76. CureVac Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 77. CureVac mRNA Therapy Product Offered
Table 78. CureVac Main Business
Table 79. CureVac mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. CureVac Latest Developments
Table 81. Translate Bio Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 82. Translate Bio mRNA Therapy Product Offered
Table 83. Translate Bio Main Business
Table 84. Translate Bio mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Translate Bio Latest Developments
Table 86. Regeneron Pharmaceuticals Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 87. Regeneron Pharmaceuticals mRNA Therapy Product Offered
Table 88. Regeneron Pharmaceuticals Main Business
Table 89. Regeneron Pharmaceuticals mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Regeneron Pharmaceuticals Latest Developments
Table 91. Arcturus Therapeutics Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 92. Arcturus Therapeutics mRNA Therapy Product Offered
Table 93. Arcturus Therapeutics Main Business
Table 94. Arcturus Therapeutics mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Arcturus Therapeutics Latest Developments
Table 96. Takeda Pharmaceutical Company Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 97. Takeda Pharmaceutical Company mRNA Therapy Product Offered
Table 98. Takeda Pharmaceutical Company Main Business
Table 99. Takeda Pharmaceutical Company mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Takeda Pharmaceutical Company Latest Developments
Table 101. Novartis Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 102. Novartis mRNA Therapy Product Offered
Table 103. Novartis mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Novartis Main Business
Table 105. Novartis Latest Developments
Table 106. Sanofi Details, Company Type, mRNA Therapy Area Served and Its Competitors
Table 107. Sanofi mRNA Therapy Product Offered
Table 108. Sanofi Main Business
Table 109. Sanofi mRNA Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. mRNA Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. mRNA Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. mRNA Therapy Sales Market Share by Country/Region (2023)
Figure 8. mRNA Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global mRNA Therapy Market Size Market Share by Type in 2023
Figure 10. mRNA Therapy in mRNA Targeted Delivery in vivo
Figure 11. Global mRNA Therapy Market: mRNA Targeted Delivery in vivo (2019-2024) & ($ Millions)
Figure 12. mRNA Therapy in Genetically Modified T cells
Figure 13. Global mRNA Therapy Market: Genetically Modified T cells (2019-2024) & ($ Millions)
Figure 14. mRNA Therapy in Transforming Nanoparticles to Develop Immunotherapy for Cancer
Figure 15. Global mRNA Therapy Market: Transforming Nanoparticles to Develop Immunotherapy for Cancer (2019-2024) & ($ Millions)
Figure 16. mRNA Therapy in Small Molecule Drugs Discovery
Figure 17. Global mRNA Therapy Market: Small Molecule Drugs Discovery (2019-2024) & ($ Millions)
Figure 18. Global mRNA Therapy Market Size Market Share by Application in 2023
Figure 19. Global mRNA Therapy Revenue Market Share by Player in 2023
Figure 20. Global mRNA Therapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas mRNA Therapy Value Market Share by Country in 2023
Figure 26. United States mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC mRNA Therapy Market Size Market Share by Region in 2023
Figure 31. APAC mRNA Therapy Market Size Market Share by Type in 2023
Figure 32. APAC mRNA Therapy Market Size Market Share by Application in 2023
Figure 33. China mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe mRNA Therapy Market Size Market Share by Country in 2023
Figure 40. Europe mRNA Therapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe mRNA Therapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa mRNA Therapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa mRNA Therapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa mRNA Therapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 59. United States mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 63. China mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 67. India mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 70. France mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 71. UK mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 80. Global mRNA Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global mRNA Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. mRNA Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. mRNA Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. mRNA Therapy Sales Market Share by Country/Region (2023)
Figure 8. mRNA Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global mRNA Therapy Market Size Market Share by Type in 2023
Figure 10. mRNA Therapy in mRNA Targeted Delivery in vivo
Figure 11. Global mRNA Therapy Market: mRNA Targeted Delivery in vivo (2019-2024) & ($ Millions)
Figure 12. mRNA Therapy in Genetically Modified T cells
Figure 13. Global mRNA Therapy Market: Genetically Modified T cells (2019-2024) & ($ Millions)
Figure 14. mRNA Therapy in Transforming Nanoparticles to Develop Immunotherapy for Cancer
Figure 15. Global mRNA Therapy Market: Transforming Nanoparticles to Develop Immunotherapy for Cancer (2019-2024) & ($ Millions)
Figure 16. mRNA Therapy in Small Molecule Drugs Discovery
Figure 17. Global mRNA Therapy Market: Small Molecule Drugs Discovery (2019-2024) & ($ Millions)
Figure 18. Global mRNA Therapy Market Size Market Share by Application in 2023
Figure 19. Global mRNA Therapy Revenue Market Share by Player in 2023
Figure 20. Global mRNA Therapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa mRNA Therapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas mRNA Therapy Value Market Share by Country in 2023
Figure 26. United States mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC mRNA Therapy Market Size Market Share by Region in 2023
Figure 31. APAC mRNA Therapy Market Size Market Share by Type in 2023
Figure 32. APAC mRNA Therapy Market Size Market Share by Application in 2023
Figure 33. China mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe mRNA Therapy Market Size Market Share by Country in 2023
Figure 40. Europe mRNA Therapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe mRNA Therapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa mRNA Therapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa mRNA Therapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa mRNA Therapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country mRNA Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 59. United States mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 63. China mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 67. India mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 70. France mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 71. UK mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries mRNA Therapy Market Size 2025-2030 ($ Millions)
Figure 80. Global mRNA Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global mRNA Therapy Market Size Market Share Forecast by Application (2025-2030)
